Biopharmaceutical Development Program (BDP)

Description:
BDP produces a variety of biopharmaceuticals for Phase I/II human clinical trials or advanced preclinical animal testing. Production services include:

• Clinical-grade biological agents from bacterial, yeast, and mammalian cells
• Natural products from various organisms
• Optimization of expression of recombinant proteins

Web Site:
http://web.ncifcrf.gov/research/brb/

Contact:
Dr. George Mitra; mitra@ncifcrf.gov

This page last updated 2007-07-20 14:24:24